Market Tracker

10/21 7:39am ET

Nektar Therapeutics (NASDAQ:NKTR)

12.86
Data as of Oct 20
 +0.46 / +3.71%
Today’s Change
8.87
Today|||52-Week Range
15.34
+13.30%
Year-to-Date

Today’s Trading

Previous close12.40
Today’s open12.41
Day’s range-- - --
Volume1,543,909
Average volume (3 months)1,311,679
Market cap$1.6B
Dividend yield--
Data as of 10/20/2014

Growth & Valuation

Earnings growth (last year)+6.67%
Earnings growth (this year)+53.84%
Earnings growth (next 5 years)+35.25%
Revenue growth (last year)+83.42%
P/E ratioNM
Price/Sales8.82
Price/Book--

Competitors

 Today’s
change
Today’s
% change
KERXKeryx Biopharmaceuti...+0.15+0.98%
DYAXDyax Corp+0.13+1.29%
ABCOAdvisory Board Co-0.14-0.28%
ARIAARIAD Pharmaceutical...+0.36+6.62%
Data as of 10/20/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)$0.39
Annual revenue (last year)$148.9M
Annual profit (last year)-$162.0M
Net profit margin-108.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts